Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study

Overview of attention for article published in Breast Cancer Research, January 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 1 news outlet
twitter: 9 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 111 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 10 X posts from 9 X users, with an upper bound of 16,358 followers.

@Thepatientnurs1 @benzosarebad @jill_d35 And what does this mean? https://t.co/w6aMddb7Iz

17 Dec 2020

Reply Repost Favourite

There has been concern about SSRI connection to breast cancer for years. https://t.co/w6aMddsIA7

15 Dec 2020

Reply Repost Favourite

Taking an SSRI antidepressant is associated with a 27% lower breast cancer survival rate. While many patients find that SSRI’s are helpful in the short-term, addressing depression using... https://t.co/npkLMRgbl2

24 Apr 2018

Reply Repost Favourite

RT @CPH_QUB: Our latest paper "Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study" is a…

02 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.